Liquiritin apioside

CAS No. 74639-14-8

Liquiritin apioside( Liquiritin apioside )

Catalog No. M19066 CAS No. 74639-14-8

Liquiritin Apioside is one of the main active components in Suan-Zao-Ren decoction as a treatment for insomnia.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 60 In Stock
2MG 29 In Stock
5MG 42 In Stock
10MG 65 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Liquiritin apioside
  • Note
    Research use only, not for human use.
  • Brief Description
    Liquiritin Apioside is one of the main active components in Suan-Zao-Ren decoction as a treatment for insomnia.
  • Description
    Liquiritin apioside is one of the main active components in Suan-Zao-Ren decoction as a treatment for insomnia.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Liquiritin apioside
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    HDAC
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    74639-14-8
  • Formula Weight
    550.51
  • Molecular Formula
    C26H30O13
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (181.65 mM)
  • SMILES
    C1[C@H](OC2=C(C1=O)C=CC(=C2)O)C3=CC=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O[C@H]5[C@@H]([C@](CO5)(CO)O)O
  • Chemical Name
    (S)-2-(4-(((2S,3R,4S,5S,6R)-3-(((2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydrofuran-2-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)phenyl)-7-hydroxychroman-4-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Du Y, et al. J Sep Sci. 2017 May;40(10):2097-2106.
molnova catalog
related products
  • 9-hydroxy Stearic Ac...

    9-hydroxy Stearic Acid is a hydroxy fatty acid that is the active metabolite of 9-PAHSA. 9-hydroxy Stearic Acid is formed from 9-PAHSA through carboxyl ester lipase in the liver and pancreas.

  • TMP-195

    A first-in-class, potent, selective class IIa HDACs (HDAC4, HDAC5, HDAC7 and HDAC9) inhibtior with IC50 of 60, 59, 26, and 15 nM, respectively.

  • CUDC-101

    A potent, multi-targeted HDAC, EGFR and HER2 inhibitor with IC50 of 4.4, 2.4, and 15.7 nM, respectively.